Stock 605186 SHANGHAI GENERAL HEALTHY INFORMATION AND TECHNOLOGY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Shanghai General Healthy Information and Technology Co., Ltd.

Equities

605186

CNE100006BJ1

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-06-12 pm EDT 		5-day change 1st Jan Change
27.2 CNY +0.74% Intraday chart for Shanghai General Healthy Information and Technology Co., Ltd. +5.06% -34.83%
Apr. 29 Shanghai General Healthy Information and Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 29 Shanghai General Healthy Information and Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

  • Overall, the company has poor fundamentals for a medium to long-term investment strategy.

Strengths

  • Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 65% by 2026.
  • The company's profit outlook over the next few years is a strong asset.
  • Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

  • The company benefits from high valuations in earnings multiples.
  • The company appears highly valued given the size of its balance sheet.
  • The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
  • Over the past four months, analysts' average price target has been revised downwards significantly.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
SHANGHAI GENERAL HEALTHY INFORMATION AND TECHNOLOGY CO., LTD. Stock Shanghai General Healthy Information and Technology Co., Ltd.
-34.83% 507M -
ABBOTT LABORATORIES Stock Abbott Laboratories
-6.01% 182B
C+
MEDTRONIC PLC Stock Medtronic plc
-0.87% 108B
C
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-4.86% 67.62B
A
DEXCOM, INC. Stock DexCom, Inc.
-8.28% 46.61B
B-
CENCORA, INC. Stock Cencora, Inc.
+13.07% 45.32B
B-
HOYA CORPORATION Stock Hoya Corporation
+4.48% 42.11B
B+
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+21.56% 31.17B
B
TERUMO CORPORATION Stock Terumo Corporation
+13.37% 25.66B
A-
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-4.50% 24.65B
A-
Investor Rating
Trading Rating
-
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
  1. Stock Market
  2. Equities
  3. 605186 Stock
  4. Ratings Shanghai General Healthy Information and Technology Co., Ltd.